coronavirus disease 2019 dissolution hydroxychloroquine sulfate pH validation

Journal

Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173

Informations de publication

Date de publication:
2020
Historique:
received: 02 10 2020
accepted: 30 11 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: epublish

Résumé

Hydroxychloroquine sulfate is one of an extensive series of 4-aminoquinolines with antimalarial activity. Moreover, it is used for the treatment of rheumatoid arthritis. Sometimes, hydroxychloroquine sulfate is beneficial for the treatment of autoimmune diseases. Based on recent clinical experiments, it is exploited for the treatment of COVID-19, coronavirus across the globe. The chromatogram separation was achieved by using Agilent, Zorbax C8, 250 mm × 4.6 mm i.d., column. The buffer consists of 0.01 M of 1-pentane sulfonic acid and 0.02% of orthophosphoric acid in purified water. Mixed buffer, acetonitrile, and methanol (800:100:100 v/v). The flow rate was 1.0 ml min

Identifiants

pubmed: 33521056
doi: 10.3389/fmolb.2020.613393
pmc: PMC7841110
doi:

Types de publication

Journal Article

Langues

eng

Pagination

613393

Informations de copyright

Copyright © 2021 Dongala, Katari, Ettaboina, Krishnan, Tambuwala and Dua.

Déclaration de conflit d'intérêts

TD and SE were employed by the company Aurex Laboratories LLC, 10 lake drive, East Windsor, NJ, USA 08512. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Pharm Biomed Anal. 2009 May 1;49(4):873-9
pubmed: 19201565
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
J Chromatogr. 1985 Mar 22;338(2):422-7
pubmed: 3873466
J Chromatogr B Biomed Appl. 1995 Apr 21;666(2):347-53
pubmed: 7633613
J Chromatogr. 1993 Apr 2;613(2):303-10
pubmed: 8491817
J Chromatogr. 1992 Oct 2;581(1):83-92
pubmed: 1430010
Int J Antimicrob Agents. 2020 Apr;55(4):105932
pubmed: 32145363
Clin Chim Acta. 2013 Jun 5;421:79-84
pubmed: 23485647
J Chromatogr. 1986 Apr 25;377:454-9
pubmed: 3711242
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
J Pharm Biomed Anal. 2012 Mar 5;61:86-92
pubmed: 22197155
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
J Pharm Biomed Anal. 2014 Jul;95:200-6
pubmed: 24682018
J Anal Toxicol. 1994 Sep;18(5):255-60
pubmed: 7990442
J Pharm Biomed Anal. 2003 Jun 1;32(2):269-75
pubmed: 12763536

Auteurs

Thirupathi Dongala (T)

Aurex Laboratories LLC, East Windsor, NJ, United States.
Department of Chemistry, School of Science GITAM Deemed to be University, Hyderabad, India.

Naresh Kumar Katari (NK)

Department of Chemistry, School of Science GITAM Deemed to be University, Hyderabad, India.

Santhosh Kumar Ettaboina (SK)

Aurex Laboratories LLC, East Windsor, NJ, United States.

Anand Krishnan (A)

Department of Chemical Pathology, Faculty of Health Sciences and National Health Laboratory Service, School of Pathology, University of the Free State, Bloemfontein, South Africa.

Murtaza M Tambuwala (MM)

School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, United Kingdom.

Kamal Dua (K)

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, NSW, Australia.
School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India.

Classifications MeSH